Skip to main content

Advertisement

Log in

Recent updates on worldwide gout epidemiology

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

To provide recent statistics on worldwide gout epidemiology. Current and prediction data on gout epidemiology were retrieved from the Global Health Data Exchange (GHDx) registry and from the World Health Organization (WHO) database on projected mortality. Overall, 7.44 million cases of gout have been estimated around the world in 2017 (incidence, 0.097%), with a prevalence of 41.22 million cases (0.54%), and causing 1.28 million DALYs (0.051% of all DALYs). Gout incidence, prevalence, and health loss considerably increased during the last 25 years and are all higher in men than in women. The burden of gout increases linearly with aging, until the age of 64 years, and is correlated with socio-demographic index (SDI), with incident risk of gout > 3-fold higher in high than in low SDI regions. Projections suggest that gout mortality may increase by 55% in 2060. The epidemiologic burden of gout remains high around the world, especially in men and in high SDI countries, with a trend that is unlikely to reverse soon.

Key Points

• A significant association can be found between gout and socioeconomic status.

• Projections suggest that gout mortality may increase by 55% in 2060.

• The epidemiologic burden of gout remains high around the world.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Fischer A, Cloutier M, Goodfield J, Borrelli R, Marvin D, Dziarmaga A (2017) The direct economic burden of gout in an elderly Canadian population. J Rheumatol 44:95–101

    Article  Google Scholar 

  2. Elfishawi MM, Zleik N, Kvrgic Z, Michet CJ Jr, Crowson CS, Matteson EL, Bongartz T (2018) The rising incidence of gout and the increasing burden of comorbidities: a population-based study over 20 years. J Rheumatol 45:574–579

    Article  Google Scholar 

  3. Cea Soriano L, Rothenbacher D, Choi HK, García Rodríguez LA (2011) Contemporary epidemiology of gout in the UK general population. Arthritis Res Ther 13:R39

    Article  Google Scholar 

  4. Pisaniello HL, Lester S, Gonzalez-Chica D, Stocks N, Longo M, Sharplin GR, Dal Grande E, Gill TK, Whittle SL, Hill CL (2018) Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study. Arthritis Res Ther 20:143

    Article  Google Scholar 

  5. Roddy E, Choi HK (2014) Epidemiology of gout. Rheum Dis Clin N Am 40:155–175

    Article  Google Scholar 

  6. Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11:649–662

    Article  Google Scholar 

  7. Pascart T, Lioté F (2019) Gout: state of the art after a decade of developments. Rheumatology (Oxford) 58:27–44

    Article  CAS  Google Scholar 

  8. Institute for Health Metrics and Evaluation Global health data exchange. Available at: http://ghdx.healthdata.org/gbd-results-tool. Last accessed, July 31, 2019

  9. Xia Y, Wu Q, Wang H, Zhang S, Jiang Y, Gong T, Xu X, Chang Q, Niu K, Zhao Y (2019) Global, regional and national burden of gout, 1990-2017: a systematic analysis of the Global Burden of Disease Study. Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/kez476

  10. GBD (2017) Disease and Injury Incidence and Prevalence Collaborators (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392:1789–1858

    Google Scholar 

  11. World Health Organization Projections of mortality and causes of death, 2016 to 2060. Available at: https://www.who.int/healthinfo/global_burden_disease/projections/en/. Last access: July 31, 2019

  12. Golenbiewski J, Keenan RT (2019) Moving the needle: improving the care of the gout patient. Rheumatol Ther 6:179–193

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuseppe Lippi.

Ethics declarations

The study was performed in accordance with the Declaration of Helsinki, under the terms of relevant local legislation.

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mattiuzzi, C., Lippi, G. Recent updates on worldwide gout epidemiology. Clin Rheumatol 39, 1061–1063 (2020). https://doi.org/10.1007/s10067-019-04868-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-019-04868-9

Keywords

Navigation